news

Non-coding RNA may interact with chromatin to control gene expression

The development of an innovative new technology has led researchers to suggest RNA-chromatin interactions may play a role in gene regulation.

Artist impression of a nucleus, cut open to reveal DNA with chromatin core inside

Researchers exploring why long non-coding RNAs attach to the chromatin on DNA have discovered it may play a role in gene regulation and chromatin organisation.

According to the scientists, this discovery and the technology they developed to make it, could lead to further findings, applications and therapeutics.

Scientists at the RIKEN Center for Integrative Medical Sciences (IMS), Japan, developed a novel technology to be able to determine whether RNA is part of chromatins structure. RNA And DNA Interacting Complexes Ligated and sequenced (RADICL-seq), which maps genome-wide RNA-chromatin interactions in intact nuclei, allowed the researchers to identify distinct patterns of genome occupancy for different classes of transcripts and cell type-specific RNA-chromatin interactions.

 

Reserve your FREE place

 


Are you looking to optimise antibody leads in your drug discovery? Register for this webinar to find out how!

30 July 2025 | 10:00 AM BST | FREE Webinar

Join this webinar to hear from Dr. Lei Guo as she shares how early insights into liability, PK, stability, and manufacturability can help you optimise antibody leads in early drug discovery – and mitigate downstream risks later in development.

What You’ll Learn:

  • How to assess key developability risks early
  • How in silico modelling and in vitro testing can be combined to predict CMC risks earlier in discovery stage
  • How micro-developability strategies are tailored for complex or novel formats

Don’t miss your chance to learn from real-world leaders

Register Now – It’s Free!

 

They revealed that the results emphasise the role of transcription in the establishment of chromatin structure.

The scientists tested their method on two non-coding RNAs known to be preferentially expressed in different cell types. NEAT1 is thought to be involved as it is associated with a structure known as paraspeckles found in mammalian cell nuclei. The other, Fgfr2 is involved in embryonic development and tissue repair, especially for bone and blood vessels.

The study, published in Nature Communications, states that in murine embryonic stem cells, NEAT1 acts almost exclusively on genomic regions of chromosome 19, from which it itself derives from, but in oligodendrocyte progenitor cells, it interacts with a broad range of genomic regions on other chromosomes as well. Fgfr2, by contrast, mostly interacts with genomic regions on its own chromosome.

“This study is a first step toward understanding how the interplay between RNA and chromatin ensures proper genome function. Our data indicate that RNAs may exert more widespread effects on gene regulation and chromatin organisation than previously thought,” said Alessandro Bonetti, a corresponding author of the study.

“The broad, genome-wide applications of this technology will help us to understand the fundamental role of non-coding RNA as a regulator of genome activity, which could lead to future applications and therapies,” concluded Piero Carninci, one of the study’s senior authors.